The specific signalling pathways activated by TGF-β in various cell types during tissue fibrosis and cancer progression are diverse and provide evidence for a complex network of signalling molecules that play important biological roles under different pathophysiological conditions. The gene discussed is TGFB1; the disease is cancer.